PharmaShots | Incisive News in 3 Shots

Subscribe Now

Fujirebio

Fujirebio Reports the Regulatory Submission of Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio IVD Test to the US FDA for Alzheimer's Disease

Fujirebio Reports the Regulatory Submission of Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio IVD Test to the US FDA for Alzheim...

September 26, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us